Evidence map›Paper›PMID 25001258›Full record

ArticleThe American journal of gastroenterology2014

Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study.

Gilles Macaigne, Pierre Lahmek, Christophe Locher, Bruno Lesgourgues, Laurent Costes, Max Pierre Nicolas, Anne Courillon-Mallet, Jean-Michel Ghilain, Guy Bellaïche, Stéphanie de Montigny-Lehnardt and 7 more

Abstract readComparative StudyMulticenter Study
PubMed Publisher
In one paragraph

Article in The American journal of gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 88 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Epidemiology of Microscopic Colitis in Olmsted County, Minnesota: Population-Based Study From 2011 to 2019.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2022
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Management of microscopic colitis: challenges and solutions.Clinical and experimental gastroenterology · 2019
    Review
  14. Review
  15. Article
  16. Fatigue and its associated factors in microscopic colitis.Therapeutic advances in gastroenterology · 2018
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 2 countries.

Gilles MacaigneService de Gastro-Entérologie, Centre Hospitalier de Marne la Vallée, Jossigny, France.
Pierre LahmekService de Gastro-Entérologie, Centre Hospitalier de Limeil-Brévannes, Limeil-Brévannes, France.
Christophe LocherService de Gastro-Entérologie, Centre Hospitalier de Meaux, Meaux, France.
Bruno LesgourguesService de Gastro-Entérologie, Centre Hospitalier Intercommunal Le Raincy-Montfermeil, Montfermeil, France.
Laurent CostesService de Gastro-Entérologie, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
Max Pierre NicolasService de Gastro-Entérologie, Centre Hospitalier de Montauban, Montauban, France.
Anne Courillon-MalletService de Gastro-Entérologie, Centre Hospitalier Intercommunal de Villeneuve Saint-Georges, Villeneuve Saint-Georges, France.
Jean-Michel GhilainService de Gastro-Entérologie, Centre Hospitalier de Jolimont, Jolimont, Belgique.
Guy BellaïcheService de Gastro-Entérologie, Centre Hospitalier Intercommunal d'Aulnay sous Bois, Aulnay sous bois, France.
Stéphanie de Montigny-LehnardtService de Gastro-Entérologie, Centre Hospitalier d'Aubagne, Aubagne, France.
Georges BarjonetService de Gastro-Entérologie, Centre Hospitalier de Coulommiers, Coulommiers, France.
René-Louis VitteService de Gastro-Entérologie, Centre Hospitalier Intercommunal de Poissy, Poissy, France.
Roger FarouxService de Gastro-Entérologie, Centre Hospitalier départemental de La Roche sur Yon, La Roche sur Yon, France.
Benedicte LambareService de Gastro-Entérologie, Centre Hospitalier Sud Francilien, Evry, France.
Antoine FleuryService de Gastro-Entérologie, Centre Hospitalier de Neuilly sur Seine, Neuilly sur seine, France.
Alexandre Pariente1] Service de Gastro-Entérologie, Centre Hospitalier de Pau, Pau, France [2] These authors contributed equally to this work.
Stéphane Nahon1] Service de Gastro-Entérologie, Centre Hospitalier Intercommunal Le Raincy-Montfermeil, Montfermeil, France [2] These authors contributed equally to this work [3] Full investigators are listed before study highlights.
Groupe Hospitalier Intercommunal Le Raincy Montfermeil · FRCentre Hospitalier De Pau · FRCentre Hospitalier Edmond Garcin · FRCentre Hospitalier Intercommunal de Poissy · FRCentre Hospitalier Intercommunal de Villeneuve-Saint-Georges · FRCentre hospitalier Robert-Ballanger · FRCentre Hospitalier Sud Francilien · FRHôpital de Jolimont · BEHôpital Intercommunal de Créteil · FRRoche (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo describe the characteristics of a cohort of patients with microscopic colitis (MC; lymphocytic (LC) or collagenous (CC) colitis) and to compare them with patients with functional bowel disorder with diarrhea (FBD-D).

methodsBetween September 2010 and June 2012, patients fulfilling the following inclusion criteria were prospectively included in 26 centers in France: (i) having at least three bowel movements daily with change in stool consistency; (ii) duration of abnormal bowel habit >4 weeks; and (iii) normal or near-normal colonoscopy. Each patient underwent a colonoscopy and colonic biopsies. We compared the demographic, clinical, biological, and etiological characteristic of patients with MC (CC and LC) with those of control patients with FBD-D.

resultsA total of 433 patients were included: 129 with MC (87 LC and 42 CC), 23 with another organic disease, and 278 with FDB-D, including patients with diarrhea and abdominal pain who met the criteria of Rome III (irritable bowel syndrome with diarrhea) and patients with functional diarrhea without abdominal pain. Logistic regression analysis identified the following independent predictors of MC: age >50 years (odds ratio (OR)=3.1, 95% confidence interval (CI)=1.6-5.9), presence of nocturnal stools (OR=2, 95% CI=1.1-3.9), weight loss (OR=2.5, 95% CI=1.3-4.7), duration of diarrhea <12 months (OR=2.0, 95% CI=1.1-3.5), recent introduction of new drugs (OR=3.7, 95% CI=2.1-6.6; P<0.0001), and the presence of a known autoimmune disorder (OR=5.5, 95% CI=2.5-12).

conclusionsAge >50 years, the presence of nocturnal stools, weight loss, the introduction of a new drug, and the presence of a known autoimmune disease increase the probability of MC and thus the indication for colonoscopy with biopsies.

Indexed as

Abdominal PainAdultAgedAge FactorsAutoimmune DiseasesBiopsyCase-Control StudiesColitis, CollagenousColitis, LymphocyticColonColonoscopyDefecationDiarrheaFemaleFranceHumans

Identifiers

PMID25001258
OpenAlexW1986676290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.